Trends in Gene:免疫基因的突变或为器官移植带来麻烦

2012-08-07 T.Shen 生物谷

8月3日,刊登在国际著名杂志Trends in Genetics上的一篇研究报告指出,人类的HLA(组织相容性抗原)基因进化比科学家认为的要快得多。这种进化上的改变可以改变我们抵御疾病的能力,HLA基因可以允许我们自身免疫系统区分自身细胞和外来侵入者。 HLA蛋白位于人类细胞表面,每一个个体在其细胞表面都有特异性的HLA蛋白,这些蛋白质可以扮演身份证的作用。拥有相同HLA的其它细胞被认为是自身细

8月3日,刊登在国际著名杂志Trends in Genetics上的一篇研究报告指出,人类的HLA(组织相容性抗原)基因进化比科学家认为的要快得多。这种进化上的改变可以改变我们抵御疾病的能力,HLA基因可以允许我们自身免疫系统区分自身细胞和外来侵入者。

HLA蛋白位于人类细胞表面,每一个个体在其细胞表面都有特异性的HLA蛋白,这些蛋白质可以扮演身份证的作用。拥有相同HLA的其它细胞被认为是自身细胞,外来的病毒或者细菌被认为是外来入侵者,免疫系统会及时识别并将其清理掉,我们的机体对于移植入的组织视为外来者,因此拒绝其的加入,除非病人和捐献者的HLA基因相同,因此,全世界的科学家正在努力去寻找可能的HLA突变体,希望提高病人和捐献者配对成功率。

HLA的突变非常快速,研究者在现在的人口中建立了超过100万的突变体。尽全力去识别所有的突变体几乎不可能,因为这些基因进化的速度非常之快。当然了快速进化从某种意义上来说也是一种方便,因为这意味着,在人口水平上,我们的免疫系统变得更加可以抵御致病菌的感染了。对于移植器官接受者来说,配对成功的最佳机会是在一级亲属中寻找,而不是在全世界范围内寻找合适的捐献者。

编译自:Unexpected Variation in Immune Genes Poses Difficulties for Transplantation

doi:10.1016/j.tig.2012.06.007
PMC:
PMID:

New reservoirs of HLA alleles: pools of rare variants enhance immune defense

William Klitz1, , Philip Hedrick2, Edward J. Louis3

Highly polymorphic exons of the major histocompatibility complex (MHC, or HLA in humans) encode critical amino acids that bind foreign peptides. Recognition of the peptide–MHC complexes by T cells initiates the adaptive immune response. The particular structure of these exons facilitates gene conversion(GC) events, leading to the generation of new alleles. Estimates for allele creation and loss indicate that more than 10 000 such alleles are circulating at low frequencies in human populations. Empirical sampling has affirmed this expectation. This suggests that the MHC loci have a system for moving valuable and often complex variants into adaptive service. Here, we argue that HLA loci carry many new mutant alleles prepared to assume epidemiologically meaningful roles when called on by selection provoked by exposure to new and evolving pathogens. Because new mutant alleles appear in a population at the lowest possible frequency (i.e., a single copy), they have typically been thought of as having little consequence. However, this large population of rare yet potentially valuable new alleles may contribute to pathogen defense.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1785260, encodeId=27531e8526017, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Sat May 11 04:18:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660332, encodeId=a85e166033213, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Thu Mar 21 21:18:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905681, encodeId=5a02190568167, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sun Jun 09 09:18:00 CST 2013, time=2013-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048471, encodeId=f96320484e164, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Tue Jul 02 10:18:00 CST 2013, time=2013-07-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1785260, encodeId=27531e8526017, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Sat May 11 04:18:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660332, encodeId=a85e166033213, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Thu Mar 21 21:18:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905681, encodeId=5a02190568167, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sun Jun 09 09:18:00 CST 2013, time=2013-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048471, encodeId=f96320484e164, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Tue Jul 02 10:18:00 CST 2013, time=2013-07-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1785260, encodeId=27531e8526017, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Sat May 11 04:18:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660332, encodeId=a85e166033213, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Thu Mar 21 21:18:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905681, encodeId=5a02190568167, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sun Jun 09 09:18:00 CST 2013, time=2013-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048471, encodeId=f96320484e164, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Tue Jul 02 10:18:00 CST 2013, time=2013-07-02, status=1, ipAttribution=)]
    2013-06-09 freve
  4. [GetPortalCommentsPageByObjectIdResponse(id=1785260, encodeId=27531e8526017, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Sat May 11 04:18:00 CST 2013, time=2013-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1660332, encodeId=a85e166033213, content=<a href='/topic/show?id=2ea628999ab' target=_blank style='color:#2F92EE;'>#免疫基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28999, encryptionId=2ea628999ab, topicName=免疫基因)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14a125104239, createdName=lsj636, createdTime=Thu Mar 21 21:18:00 CST 2013, time=2013-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905681, encodeId=5a02190568167, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Sun Jun 09 09:18:00 CST 2013, time=2013-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048471, encodeId=f96320484e164, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Tue Jul 02 10:18:00 CST 2013, time=2013-07-02, status=1, ipAttribution=)]
    2013-07-02 cy0324